Skip to content
PIL Logo

Clexane Forte Syringes

Last Updated on eMC 16-Sep-2015 View document  | SANOFI Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16-Sep-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 17-Feb-2014 and displayed until 16-Sep-2015

Reasons for adding or updating:

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - how to report a side effect

Updated on 01-Jul-2013 and displayed until 17-Feb-2014

Reasons for adding or updating:

  • Change to section 4 - possible side effects

Updated on 31-May-2013 and displayed until 01-Jul-2013

Reasons for adding or updating:

  • Change to information for healthcare professionals

Updated on 13-Jul-2012 and displayed until 31-May-2013

Reasons for adding or updating:

  • Change to Marketing Authorisation Holder

Updated on 23-Feb-2012 and displayed until 13-Jul-2012

Reasons for adding or updating:

  • Change to dosage and administration

Updated on 11-Mar-2011 and displayed until 23-Feb-2012

Reasons for adding or updating:

  • Change to side-effects

Updated on 21-Dec-2010 and displayed until 11-Mar-2011

Reasons for adding or updating:

  • Change to, or new, use for medicine

Updated on 14-Oct-2010 and displayed until 21-Dec-2010

Reasons for adding or updating:

  • Change to dosage and administration

Updated on 19-Dec-2008 and displayed until 14-Oct-2010

Reasons for adding or updating:

  • Change of manufacturer

Updated on 08-May-2007 and displayed until 19-Dec-2008

Reasons for adding or updating:

  • Change to date of revision

Updated on 22-Nov-2004 and displayed until 08-May-2007

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation

Updated on 18-Mar-2003 and displayed until 22-Nov-2004

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Company contact details

SANOFI

Company image
Address

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK

Fax

+44 (0)1483 535 432

Medical Information e-mail
Telephone

+44 (0)1483 505 515

Medical Information Direct Line

+44 (0)845 372 7101

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

enoxaparin sodium

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue